UBS says Hong Kong equity market has been highly active with a structural shift
toward hard-tech and new-economy issuers; sci‑tech firms accounted for 63% of HK
IPO volume YTD versus 16% a year earlier. UBS investment banking co-head says HK
equity financing reached about $43 bln in the first five months of 2026, up from
$28 bln a year earlier. UBS Research forecasts full-year Hong Kong IPO proceeds
of $45–50 bln and remains confident the HSI will break 30,000 this year. Looking
to H2, UBS expects China market momentum to be driven by substantive corporate
profit growth and prefers two asset types: large-cap tech leaders benefitting
from global AI deployment and technology self-sufficiency, and small/mid-cap
firms with structural overseas-expansion capabilities.
